Abstracts

IMPLEMENTATION OF ON-DEMAND PrEP IN A LARGE INTEGRATED HEALTH CARE SYSTEM

Data describing real-world implementation of on-demand (2-1-1) HIV preexposure prophylaxis (PrEP) are limited. In this study, we report on the experiences of early 2-1-1 adopters in Kaiser Permanente San Francisco (KPSF). KPSF started offering 2-1-1 PrEP in February, 2019. We abstracted data from the electronic health record, including demographics, reasons for selecting 2-1-1, and self-reported…

HIV-1 DRUG RESISTANCE IN THE DISCOVER PREEXPOSURE PROPHYLAXIS TRIAL

The DISCOVER study is an ongoing randomized, double‑blind study of pre-exposure prophylaxis (PrEP) using daily FTC/TAF (F/TAF; Descovy; DVY) or FTC/TDF (F/TDF; Truvada; TVD) in men or transgender women who have sex with men. Of the 5,335 randomized participants, 23 participants (0.4%) became infected with HIV-1 through 96 weeks on study. The infected participants from…

THE POTENTIAL FOR A RECTAL MICROBICIDE DOUCHE: FINDINGS FROM AN INTERNATIONAL SURVEY

Since many individuals who engage in receptive anal intercourse (RAI) regularly use cleansing rectal douches beforehand, an HIV-prevention douche could have high acceptability. Administration of tenofovir via a rectal douche results in faster and higher drug concentration in the rectal mucosa than oral administration. We aimed to describe behavioral aspects of rectal douching before RAI in…